{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T08:55:29Z","timestamp":1778748929747,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":29,"publisher":"Springer US","isbn-type":[{"value":"9781071627068","type":"print"},{"value":"9781071627075","type":"electronic"}],"license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022]]},"DOI":"10.1007\/978-1-0716-2707-5_12","type":"book-chapter","created":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T12:02:55Z","timestamp":1661860975000},"page":"159-169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Locked Nucleic Acid AntimiR Therapy for the Heart"],"prefix":"10.1007","author":[{"given":"Sabine","family":"Samolovac","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2936-0400","authenticated-orcid":false,"given":"Rabea","family":"Hinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,31]]},"reference":[{"issue":"5","key":"12_CR1","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843\u2013854. https:\/\/doi.org\/10.1016\/0092-8674(93)90529-y","journal-title":"Cell"},{"issue":"5","key":"12_CR2","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1161\/circresaha.119.315856","volume":"126","author":"CK Huang","year":"2020","unstructured":"Huang CK, Kafert-Kasting S, Thum T (2020) Preclinical and clinical development of noncoding RNA therapeutics for cardiovascular disease. Circ Res 126(5):663\u2013678. https:\/\/doi.org\/10.1161\/circresaha.119.315856","journal-title":"Circ Res"},{"issue":"4","key":"12_CR3","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1161\/circgenetics.110.958975","volume":"4","author":"Y Kuwabara","year":"2011","unstructured":"Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M, Watanabe S, Baba O, Kojima Y, Shizuta S, Imai M, Tamura T, Kita T, Kimura T (2011) Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 4(4):446\u2013454. https:\/\/doi.org\/10.1161\/circgenetics.110.958975","journal-title":"Circ Cardiovasc Genet"},{"issue":"10","key":"12_CR4","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1161\/circresaha.108.183087","volume":"103","author":"V Divakaran","year":"2008","unstructured":"Divakaran V, Mann DL (2008) The emerging role of microRNAs in cardiac remodeling and heart failure. Circ Res 103(10):1072\u20131083. https:\/\/doi.org\/10.1161\/circresaha.108.183087","journal-title":"Circ Res"},{"issue":"10","key":"12_CR5","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1152\/physiolgenomics.00130.2010","volume":"43","author":"Y Ye","year":"2011","unstructured":"Ye Y, Perez-Polo JR, Qian J, Birnbaum Y (2011) The role of microRNA in modulating myocardial ischemia-reperfusion injury. Physiol Genomics 43(10):534\u2013542. https:\/\/doi.org\/10.1152\/physiolgenomics.00130.2010","journal-title":"Physiol Genomics"},{"issue":"5935","key":"12_CR6","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1126\/science.1174381","volume":"324","author":"A Bonauer","year":"2009","unstructured":"Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, Burchfield J, Fox H, Doebele C, Ohtani K, Chavakis E, Potente M, Tjwa M, Urbich C, Zeiher AM, Dimmeler S (2009) MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 324(5935):1710\u20131713. https:\/\/doi.org\/10.1126\/science.1174381","journal-title":"Science"},{"issue":"19","key":"12_CR7","doi-asserted-by":"publisher","first-page":"4714","DOI":"10.3390\/ijms20194714","volume":"20","author":"N Wehbe","year":"2019","unstructured":"Wehbe N, Nasser SA, Pintus G, Badran A, Eid AH, Baydoun E (2019) MicroRNAs in cardiac hypertrophy. Int J Mol Sci 20(19):4714. https:\/\/doi.org\/10.3390\/ijms20194714","journal-title":"Int J Mol Sci"},{"issue":"5","key":"12_CR8","doi-asserted-by":"publisher","first-page":"749","DOI":"10.3390\/ijms17050749","volume":"17","author":"J Wang","year":"2016","unstructured":"Wang J, Liew OW, Richards AM, Chen Y-T (2016) Overview of MicroRNAs in cardiac hypertrophy, fibrosis, and apoptosis. Int J Mol Sci 17(5):749. https:\/\/doi.org\/10.3390\/ijms17050749","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1161\/circresaha.111.244442","volume":"110","author":"TG Hullinger","year":"2012","unstructured":"Hullinger TG, Montgomery RL, Seto AG, Dickinson BA, Semus HM, Lynch JM, Dalby CM, Robinson K, Stack C, Latimer PA, Hare JM, Olson EN, van Rooij E (2012) Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res 110(1):71\u201381. https:\/\/doi.org\/10.1161\/circresaha.111.244442","journal-title":"Circ Res"},{"issue":"10","key":"12_CR10","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1161\/circulationaha.113.001904","volume":"128","author":"R Hinkel","year":"2013","unstructured":"Hinkel R, Penzkofer D, Z\u00fchlke S, Fischer A, Husada W, Xu QF, Baloch E, van Rooij E, Zeiher AM, Kupatt C, Dimmeler S (2013) Inhibition of microRNA-92a protects against ischemia\/reperfusion injury in a large-animal model. Circulation 128(10):1066\u20131075. https:\/\/doi.org\/10.1161\/circulationaha.113.001904","journal-title":"Circulation"},{"key":"12_CR11","doi-asserted-by":"publisher","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol 9(402). https:\/\/doi.org\/10.3389\/fendo.2018.00402","DOI":"10.3389\/fendo.2018.00402"},{"issue":"7068","key":"12_CR12","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/nature04303","volume":"438","author":"J Kr\u00fctzfeldt","year":"2005","unstructured":"Kr\u00fctzfeldt J, Rajewsky N, Braich R, Rajeev KG, Tuschl T, Manoharan M, Stoffel M (2005) Silencing of microRNAs in vivo with \u2018antagomirs\u2019. Nature 438(7068):685\u2013689. https:\/\/doi.org\/10.1038\/nature04303","journal-title":"Nature"},{"issue":"3","key":"12_CR13","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.hlc.2011.11.002","volume":"21","author":"BC Bernardo","year":"2012","unstructured":"Bernardo BC, Charchar FJ, Lin RC, McMullen JR (2012) A microRNA guide for clinicians and basic scientists: background and experimental techniques. Heart Lung Circ 21(3):131\u2013142. https:\/\/doi.org\/10.1016\/j.hlc.2011.11.002","journal-title":"Heart Lung Circ"},{"issue":"1","key":"12_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1758-907X-3-1","volume":"3","author":"J Stenvang","year":"2012","unstructured":"Stenvang J, Petri A, Lindow M, Obad S, Kauppinen S (2012) Inhibition of microRNA function by antimiR oligonucleotides. Silence 3(1):1\u20131. https:\/\/doi.org\/10.1186\/1758-907X-3-1","journal-title":"Silence"},{"issue":"11","key":"12_CR15","doi-asserted-by":"publisher","first-page":"2352","DOI":"10.1002\/oby.20852","volume":"22","author":"T Seeger","year":"2014","unstructured":"Seeger T, Fischer A, Muhly-Reinholz M, Zeiher AM, Dimmeler S (2014) Long-term inhibition of miR-21 leads to reduction of obesity in db\/db mice. Obesity (Silver Spring) 22(11):2352\u20132360. https:\/\/doi.org\/10.1002\/oby.20852","journal-title":"Obesity (Silver Spring)"},{"issue":"12","key":"12_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085639","volume":"8","author":"X Jia","year":"2013","unstructured":"Jia X, Zheng S, Xie X, Zhang Y, Wang W, Wang Z, Zhang Y, Wang J, Gao M, Hou Y (2013) MicroRNA-1 accelerates the shortening of atrial effective refractory period by regulating KCNE1 and KCNB2 expression: an atrial tachypacing rabbit model. PLoS One 8(12):e85639. https:\/\/doi.org\/10.1371\/journal.pone.0085639","journal-title":"PLoS One"},{"issue":"4","key":"12_CR17","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1158\/1078-0432.Ccr-20-3139","volume":"27","author":"E Anastasiadou","year":"2021","unstructured":"Anastasiadou E, Seto AG, Beatty X, Hermreck M, Gilles M-E, Stroopinsky D, Pinter-Brown LC, Pestano L, Marchese C, Avigan D, Trivedi P, Escolar DM, Jackson AL, Slack FJ (2021) Cobomarsen, an oligonucleotide inhibitor of miR-155, slows DLBCL tumor cell growth in vitro and in vivo. Clin Cancer Res 27(4):1139\u20131149. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-3139","journal-title":"Clin Cancer Res"},{"issue":"26","key":"12_CR18","doi-asserted-by":"publisher","first-page":"E1695","DOI":"10.1073\/pnas.1201516109","volume":"109","author":"IA Babar","year":"2012","unstructured":"Babar IA, Cheng CJ, Booth CJ, Liang X, Weidhaas JB, Saltzman WM, Slack FJ (2012) Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci 109(26):E1695\u2013E1704. https:\/\/doi.org\/10.1073\/pnas.1201516109","journal-title":"Proc Natl Acad Sci"},{"key":"12_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.omtn.2018.02.005","volume":"11","author":"H Javanbakht","year":"2018","unstructured":"Javanbakht H, Mueller H, Walther J, Zhou X, Lopez A, Pattupara T, Blaising J, Pedersen L, Alb\u00e6k N, Jackerott M, Shi T, Ploix C, Driessen W, Persson R, Ravn J, Young JAT, Ottosen S (2018) Liver-targeted anti-HBV single-stranded oligonucleotides with locked nucleic acid potently reduce HBV gene expression in vivo. Molecular Therapy - Nucleic Acids 11:441\u2013454. https:\/\/doi.org\/10.1016\/j.omtn.2018.02.005","journal-title":"Molecular Therapy - Nucleic Acids"},{"key":"12_CR20","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.bbrc.2011.05.016","volume":"409","author":"Z Sun","year":"2011","unstructured":"Sun Z, Xiang W, Guo Y, Chen Z, Liu W, Lu D (2011) Inhibition of hepatitis B virus (HBV) by LNA-mediated nuclear interference with HBV DNA transcription. Biochem Biophys Res Commun 409:430\u2013435. https:\/\/doi.org\/10.1016\/j.bbrc.2011.05.016","journal-title":"Biochem Biophys Res Commun"},{"issue":"22","key":"12_CR21","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/circulationaha.118.034598","volume":"138","author":"EM Rogg","year":"2018","unstructured":"Rogg EM, Abplanalp WT, Bischof C, John D, Schulz MH, Krishnan J, Fischer A, Poluzzi C, Schaefer L, Bonauer A, Zeiher AM, Dimmeler S (2018) Analysis of cell type-specific effects of MicroRNA-92a provides novel insights into target regulation and mechanism of action. Circulation 138(22):2545\u20132558. https:\/\/doi.org\/10.1161\/circulationaha.118.034598","journal-title":"Circulation"},{"issue":"43","key":"12_CR22","doi-asserted-by":"publisher","first-page":"17615","DOI":"10.1073\/pnas.1206432109","volume":"109","author":"BC Bernardo","year":"2012","unstructured":"Bernardo BC, Gao X-M, Winbanks CE, Boey EJH, Tham YK, Kiriazis H, Gregorevic P, Obad S, Kauppinen S, Du X-J, Lin RCY, McMullen JR (2012) Therapeutic inhibition of the miR-34 family attenuates pathological cardiac remodeling and improves heart function. Proc Natl Acad Sci 109(43):17615\u201317620. https:\/\/doi.org\/10.1073\/pnas.1206432109","journal-title":"Proc Natl Acad Sci"},{"issue":"12","key":"12_CR23","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.1096\/fj.14-253856","volume":"28","author":"BC Bernardo","year":"2014","unstructured":"Bernardo BC, Nguyen SS, Winbanks CE, Gao XM, Boey EJ, Tham YK, Kiriazis H, Ooi JY, Porrello ER, Igoor S, Thomas CJ, Gregorevic P, Lin RC, Du XJ, McMullen JR (2014) Therapeutic silencing of miR-652 restores heart function and attenuates adverse remodeling in a setting of established pathological hypertrophy. FASEB J 28(12):5097\u20135110. https:\/\/doi.org\/10.1096\/fj.14-253856","journal-title":"FASEB J"},{"issue":"2","key":"12_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0090337","volume":"9","author":"BC Bernardo","year":"2014","unstructured":"Bernardo BC, Gao XM, Tham YK, Kiriazis H, Winbanks CE, Ooi JY, Boey EJ, Obad S, Kauppinen S, Gregorevic P, Du XJ, Lin RC, McMullen JR (2014) Silencing of miR-34a attenuates cardiac dysfunction in a setting of moderate, but not severe, hypertrophic cardiomyopathy. PLoS One 9(2):e90337. https:\/\/doi.org\/10.1371\/journal.pone.0090337","journal-title":"PLoS One"},{"issue":"7756","key":"12_CR25","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-019-1191-6","volume":"569","author":"K Gabisonia","year":"2019","unstructured":"Gabisonia K, Prosdocimo G, Aquaro GD, Carlucci L, Zentilin L, Secco I, Ali H, Braga L, Gorgodze N, Bernini F, Burchielli S, Collesi C, Zandon\u00e0 L, Sinagra G, Piacenti M, Zacchigna S, Bussani R, Recchia FA, Giacca M (2019) MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs. Nature 569(7756):418\u2013422. https:\/\/doi.org\/10.1038\/s41586-019-1191-6","journal-title":"Nature"},{"issue":"2","key":"12_CR26","first-page":"179","volume":"38","author":"M Banovic","year":"2011","unstructured":"Banovic M, Ostojic MC, Bartunek J, Nedeljkovic M, Beleslin B, Terzic A (2011) Brachial approach to NOGA-guided procedures: electromechanical mapping and transendocardial stem-cell injections. Tex Heart Inst J 38(2):179\u2013182","journal-title":"Tex Heart Inst J"},{"issue":"15","key":"12_CR27","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/j.jacc.2020.02.041","volume":"75","author":"R Hinkel","year":"2020","unstructured":"Hinkel R, Ramanujam D, Kaczmarek V, Howe A, Klett K, Beck C, Dueck A, Thum T, Laugwitz K-L, Maegdefessel L, Weber C, Kupatt C, Engelhardt S (2020) AntimiR-21 prevents myocardial dysfunction in a pig model of ischemia\/reperfusion injury. J Am Coll Cardiol 75(15):1788\u20131800. https:\/\/doi.org\/10.1016\/j.jacc.2020.02.041","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"12_CR28","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1016\/j.jacc.2021.04.028","volume":"77","author":"R Hinkel","year":"2021","unstructured":"Hinkel R, Batkai S, B\u00e4hr A, Bozoglu T, Straub S, Borchert T, Viereck J, Howe A, Hornaschewitz N, Oberberger L, Jurisch V, Kozlik-Feldmann R, Freudenthal F, Ziegler T, Weber C, Sperandio M, Engelhardt S, Laugwitz KL, Moretti A, Klymiuk N, Thum T, Kupatt C (2021) AntimiR-132 attenuates myocardial hypertrophy in an animal model of percutaneous aortic constriction. J Am Coll Cardiol 77(23):2923\u20132935. https:\/\/doi.org\/10.1016\/j.jacc.2021.04.028","journal-title":"J Am Coll Cardiol"},{"key":"12_CR29","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/978-1-4939-6588-5_18","volume":"1521","author":"R Hinkel","year":"2017","unstructured":"Hinkel R, Kupatt C (2017) Selective pressure-regulated Retroinfusion for gene therapy application in ischemic heart disease. Methods Mol Biol 1521:249\u2013260. https:\/\/doi.org\/10.1007\/978-1-4939-6588-5_18","journal-title":"Methods Mol Biol"}],"container-title":["Methods in Molecular Biology","Cardiac Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-2707-5_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T05:05:11Z","timestamp":1673586311000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-2707-5_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"ISBN":["9781071627068","9781071627075"],"references-count":29,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-2707-5_12","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"31 August 2022","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}